Product
8 Interestana reports mention CRISPR-Cas9, newest first. Each is summarised from the original reporting and links back to its publisher.
Anthropic's artificial intelligence research division has identified novel DNA editing systems within viruses that exhibit capabilities analogous to CRISPR-Cas9 technology. This discovery was made through an extensive computational analysis involving approximately 950 AI agents, which collectively dedicated over 21 hours…
A recent publication in the esteemed scientific journal Nature, dated September 28, 2026, introduces a new generation of genome editing technologies poised to significantly expand the scope of genetic manipulation.
Anthropic announced on May 15, 2024, that its artificial intelligence model, Claude, has discovered a novel enzyme system with capabilities similar to CRISPR gene-editing technology. This scientific breakthrough was revealed by the AI safety and research company amid a period…
Europe is currently deliberating new guidelines for the cultivation of gene-edited plants, a move that could significantly impact agricultural practices and food production across the continent. The discussion centers on how to regulate crops developed using techniques like CRISPR-Cas9…
Two children have died in China following experimental gene therapies, a development that has prompted calls for enhanced public disclosure of such incidents and raises questions about the future of gene therapy research in the country.
Gene editing technologies, particularly CRISPR-Cas9, have emerged as a revolutionary force in medicine, offering unprecedented potential to treat and cure genetic diseases. The ability to precisely alter DNA sequences holds promise for conditions previously considered untreatable, such as cystic fibrosis…
A recent case in China involving gene therapy has underscored the profound ethical challenges inherent in this rapidly advancing field of medicine. Gene therapy, which involves modifying a patient's genes to treat or cure diseases, holds immense promise but also…
Dolly the sheep, the first mammal cloned from an adult somatic cell, continues to hold significant relevance in discussions surrounding reproductive technologies and gene editing, over 30 years after her birth on July 5, 1996.